FindTrial
Sign In

Exploring how pressure biofeedback technology combined with traditional therapy helps stroke survivors regain stability, balance, and independence through targeted core muscle training

Optimization of Core Stabilization Training Using Pressure Biofeedback Combined with Conventional Therapy on Trunk Performance, Balance and Functional Mobility in Stroke: A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088204
Enrollment
36
Registered
2025-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G811- Spastic hemiplegia

Interventions

Intervention1: Core Stabilization Training Using Pressure Biofeedback: In the international/ experimental group, core stability training by using pressure biofeedback with conventional therapy for add

Sponsors

Sancheti Institute for Orthopaedics and Rehabilitation College of Physiotherapy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with CVA 2. Mini Mental State Examination (MMSE)score of 24 and above 3. Patients of any gender 4. Age 45-65 years

Exclusion criteria

Exclusion criteria: 1. With serious cognitive, speech, vision disorders. 2. With other nervous system diseases causing balance dysfunction. 3. Recent surgical procedure or fracture of lower extremity.

Design outcomes

Primary

MeasureTime frame
Balance (MDRT)Timepoint: At Baseline (Week0) Post Intervention (week4)—

Secondary

MeasureTime frame
Trunk Performance Functional MobilityTimepoint: At Baseline (Week0) Post Intervention (week4)—

Countries

India

Contacts

Public ContactDr Sadhana Mukhi

Sancheti Institute for Orthopaedics and Rehabilitation College of Physiotherapy

sadhananimbhore123@gmail.com8007011772

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026